Home News Regeneron accused of ‘fraudulent’ drug-pricing reporting for eye drug Eylea News Regeneron accused of ‘fraudulent’ drug-pricing reporting for eye drug Eylea By Becki Fleishman - April 11, 2024 229 0 FacebookTwitterPinterestWhatsApp Make Money Online Please enable JS and disable any ad blocker Read More